News

Techmark movers: GeneMedix falls on AIM listing cancellation

09 February 2007 14:54:00

Biopharmaceutical firm GeneMedix fell after it delayed its admission on AIM and the cancellation of its listing on the official list.

The group said the delay has been due to it failing to satisfy the requirements for the transition on time. Admission on AIM will now take place on 16 February.

IT and telecoms group Redstone is one of the big risers amongst the TechMark movers as it announced yesterday that it was acquiring network infrastructure specialist Comunica Holdings for £22m.

The shares did not react to the news yesterday but have risen 5% today.

The group also proposed to place 266m new shares at 6.75p each to part fund the acquisition.
FTSE TechMARK - Risers
Network Technology (NTY) 111.00p +20.00%
Total Systems (TTS) 40.00p +11.11%
ARC International (ARK) 41.00p +5.81%
Redstone (RED) 7.75p +5.08%
Wolfson Microelectronics (WLF) 322.50p +5.05%
Oxford Instruments (OXIG) 290.00p +4.69%
Antisoma (ASM) 46.75p +3.89%
Trafficmaster (TFC) 66.00p +2.72%
Aveva Group (AVV) 987.50p +2.20%
Biocompatibles International (BII) 148.00p +2.07%
FTSE TechMARK - Fallers
GeneMedix (GMX) 4.75p -5.00%
Ferraris Group (FER) 19.50p -4.88%
Vislink (VLK) 99.00p -3.18%
Inion (IIN) 27.00p -2.70%
Revenue Assurances Services (RAS) 108.50p -2.69%
XTL Biopharmaceuticals (XTL) 20.75p -2.35%
Amstrad (AMT) 154.75p -2.06%
Gresham Computing (GHT) 138.00p -1.95%
Protherics (PTI) 75.75p -1.94%
iSOFT Group (IOT) 52.00p -1.89%

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.